Skip to Main Content

Author Details

Jana K Shirey-Rice
Vanderbilt University School of Medicine
2008
29
14
PMIDPaper TitleJournal TitlePublished Year
36702174Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19.Anaerobe2023
36472455Interactive network-based clustering and investigation of multimorbidity association matrices with associationSubgraphs.Bioinformatics2023
32958289The Astounding Breadth of Health Disparity: Phenome-Wide Effects of Race on Disease Risk.J Natl Med Assoc2021
34394194Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases.Front Genet2021
33051675PheWAS-ME: a web-app for interactive exploration of multimorbidity patterns in PheWAS.Bioinformatics2021
31337270Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data.Annu Rev Pharmacol Toxicol2020
32112228Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use.Drug Saf2020
31454829Acute kidney injury risk-based screening in pediatric inpatients: a pragmatic randomized trial.Pediatr Res2020
30782860A Phenome-Wide Association Study Uncovers a Pathological Role of Coagulation Factor X during <i>Acinetobacter baumannii</i> Infection.Infect Immun2019
31769998Systematically Prioritizing Candidates in Genome-Based Drug Repurposing.Assay Drug Dev Technol2019
29016793Mining 100 million notes to find homelessness and adverse childhood experiences: 2 case studies of rare and severe social determinants of health in electronic health records.J Am Med Inform Assoc2018
30066313Reply to Ward and Colleagues' Comment on "Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors".Drug Saf2018
29788759Advocating for mutually beneficial access to shelved compounds.Future Med Chem2018
29185237Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors.Drug Saf2018
29218624Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.Target Oncol2018
29193979When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.Assay Drug Dev Technol2017
28486440Electronic health record-based predictive models for acute kidney injury screening in pediatric inpatients.Pediatr Res2017
28379727Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.Assay Drug Dev Technol2017
26319754Acute Kidney Injury Incidence in Noncritically Ill Hospitalized Children, Adolescents, and Young Adults: A Retrospective Observational Study.Am J Kidney Dis2016
24456567The CTSA Consortium's Catalog of Assets for Translational and Clinical Health Research (CATCHR).Clin Transl Sci2014
24534443Secondary use of clinical data: the Vanderbilt approach.J Biomed Inform2014
23580201Norepinephrine transporter variant A457P knock-in mice display key features of human postural orthostatic tachycardia syndrome.Dis Model Mech2013
24102798Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior.Genes Brain Behav2013
20582339Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.Mol Biosyst2010
19047481Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity.Mol Pharmacol2009
19906975A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning.J Neurosci2009
19705385Synthesis and structure-activity relationships of allosteric potentiators of the m(4) muscarinic acetylcholine receptor.ChemMedChem2009
18059262An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission.Nat Chem Biol2008
18772318Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats.J Pharmacol Exp Ther2008
  • 1 - 29 of 29

Recommended Authors

Megan M Shuey
Vanderbilt University Medical Center
Career Start Year 2013
Number of shared co-authors 11
Timothy S Chang
David Geffen School of Medicine, University of California los angeles
Career Start Year 2012
Number of shared co-authors 0
Nicholas P Tatonetti
Columbia Universtiy College of Physicians and Surgeons
Career Start Year 2009
Number of shared co-authors 3
Lawrence Lin
University of California San Francisco
Career Start Year 2009
Number of shared co-authors 1
Alexander W Charney
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 3
Michael Fralick
University of Toronto
Career Start Year 2007
Number of shared co-authors 0
Joel T Dudley
Institute for Next Generation Healthcare
Career Start Year 2006
Number of shared co-authors 2
Bryan L Roth
UNC School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Janey Wang
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 7
Noel Southall
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Noura S Abul-Husn
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai
Career Start Year 2002
Number of shared co-authors 7
Vincent Setola
West Virginia University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Xin-Qun Wang
University of Virginia Health System
Career Start Year 2001
Number of shared co-authors 4
Andrew B Crouse
The Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham
Career Start Year 2001
Number of shared co-authors 0
Christopher J Langmead
Monash University
Career Start Year 2000
Number of shared co-authors 0
Lara M Mangravite
Children's Hospital Oakland Research Institute
Career Start Year 1998
Number of shared co-authors 3
Michael R Barnes
William Harvey Research Institute, Queen Mary University of London
Career Start Year 1997
Number of shared co-authors 5
Brinda K Rana
University of California
Career Start Year 1996
Number of shared co-authors 0
Balwinder Singh
Mayo Clinic
Career Start Year 1994
Number of shared co-authors 0
Huy Nguyen
The University of Danang-University of Science and Technology
Career Start Year 1993
Number of shared co-authors 0
Roy H Perlis
Center for Quantitative Health, Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 3
Christophe G Lambert
University of New Mexico
Career Start Year 1992
Number of shared co-authors 0
Xi-Ping Huang
University of North Carolina School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Bruce C Carleton
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 1
Christopher P Austin
St. George's University Medical School
Career Start Year 1990
Number of shared co-authors 0
Russell A Wilke
University of South Dakota Sanford School of Medicine
Career Start Year 1989
Number of shared co-authors 11
Isaac S Kohane
Harvard Medical School
Career Start Year 1983
Number of shared co-authors 10
Russ B Altman
Stanford University
Career Start Year 1982
Number of shared co-authors 6
Brian D Athey
University of Michigan Medical School ann arbor
Career Start Year 1977
Number of shared co-authors 1

Collaborators

Jill M Pulley
Vanderbilt University School of Medicine
Co-authored papers 17
Rebecca N Jerome
12328Vanderbilt University Medical Center
Co-authored papers 12
Gordon R Bernard
Vanderbilt University
Co-authored papers 9
Nicole M Zaleski
Co-authored papers 8
Robert R Lavieri
Vanderbilt University Medical Center
Co-authored papers 7
Dan M Roden
Vanderbilt University Medical Center
Co-authored papers 6
David M Aronoff
Indiana University School of Medicine
Co-authored papers 6
Kenneth J Holroyd
Center for Technology Transfer and Commercialization, Vanderbilt University
Co-authored papers 6
Joshua C Denny
Vanderbilt University
Co-authored papers 6
Paul A Harris
School of Clinical Medicine, University of the Witwatersrand
Co-authored papers 3
Daniel W Byrne
Vanderbilt University Medical Center
Co-authored papers 3
Tracy L McGregor
Alnylam Pharmaceuticals
Co-authored papers 3
Sara L Van Driest
National Institutes of Health
Co-authored papers 3
Lisa Bastarache
Vanderbilt University Medical Center
Co-authored papers 3
Geoffrey M Fleming
Vanderbilt University School of Medicine
Co-authored papers 3
Li Wang
Vanderbilt University
Co-authored papers 3
Asli Ozdas
Vanderbilt University Medical Center
Co-authored papers 2
Michael F McLemore
Tennessee Valley Healthcare System, Veterans Affairs Medical Center
Co-authored papers 2
Cosmin A Bejan
Duke University
Co-authored papers 2
Leslie J Crofford
Vanderbilt University School of Medicine
Co-authored papers 2
Ingrid A Mayer
Vanderbilt University Medical Center
Co-authored papers 2
Melissa A Basford
Vanderbilt University
Co-authored papers 2
Christopher J Lindsell
Duke University
Co-authored papers 2
Ioana Danciu
Oak Ridge National Laboratory
Co-authored papers 2
Talat Alp Ikizler
Vanderbilt University Medical Center
Co-authored papers 1
Meghan Morrison Joly
Vanderbilt University Medical Center
Co-authored papers 1
James J Doherty
Research and Non-clinical Development, Inc.
Co-authored papers 1
Loren Lipworth
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Co-authored papers 1
Sarah K McGill
University of North Carolina School of Medicine
Co-authored papers 1
Firas H Wehbe
Feinberg School of Medicine, Northwestern University
Co-authored papers 1
Release 1.2